Christine A. Pellizzari - 28 Apr 2023 Form 4 Insider Report for Science 37 Holdings, Inc.

Role
Chief Legal and HR Officer
Signature
/s/ Christine Pellizzari
Issuer symbol
N/A
Transactions as of
28 Apr 2023
Net transactions value
$0
Form type
4
Filing time
02 May 2023, 16:20:37 UTC
Previous filing
21 Mar 2023
Next filing
22 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNCE Common Stock Award +702,332 +9364% 709,832 28 Apr 2023 Direct F1, F2, F3, F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNCE Stock Option Disposed to Issuer -1,270,739 -100% 0 28 Apr 2023 Common Stock 1,270,739 $9.49 Direct F1, F6
transaction SNCE Stock Option Disposed to Issuer -238,095 -100% 0 28 Apr 2023 Common Stock 238,095 $11.47 Direct F2
transaction SNCE Stock Option Disposed to Issuer -247,000 -100% 0 28 Apr 2023 Common Stock 247,000 $10.05 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 1,270,739 shares of common stock of the issuer and in exchange issued to the reporting person 508,295 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
F2 On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 238,095 shares of common stock of the issuer and in exchange issued to the reporting person 95,237 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
F3 On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 247,000 shares of common stock of the issuer and in exchange issued to the reporting person 98,800 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
F4 Includes 2,500 shares acquired under the issuer's Employee Stock Purchase Plan.
F5 Includes 702,332 restricted stock units, which will vest in three equal annual installments beginning on April 28, 2024, subject to continued employment.
F6 The total amount has been adjusted to add 29 derivative securities that were not previously included due to a rounding error.